990 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Not yet recruiting Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
Condition: Bronchial Cancer
Intervention: Device: With and without SDB
4 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
5 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
6 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
7 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
8 Recruiting Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib
Conditions: Lung Adenocarcinoma;   Lung Neoplasms
Interventions: Drug: osimertinib;   Other: LAT
9 Not yet recruiting Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases
Conditions: Prostate Cancer;   Breast Cancer;   Carcinoma, Non-Small-Cell Lung
Interventions: Radiation: SBRT;   Other: Standard of Care
10 Not yet recruiting A Study to Assess Safety, Tolerability and Preliminary Activity of the Combination of FAK (Defactinib) and PD-1(Pembrolizumab) Inhibition in Patients With Advanced Solid Malignancies
Conditions: Carcinoma, Non-small-cell Lung;   Mesothelioma;   Pancreatic Neoplasms
Interventions: Drug: Defactinib;   Drug: Pembrolizumab
11 Recruiting Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients
Condition: Non-Small Cell Lung Cancer
Intervention: Other: Evaluation of PD-1/PDL-1 expression.
12 Not yet recruiting Patient Navigation for Lung Cancer Screen in an Urban Safety-Net System
Conditions: Non-Small Cell Lung Carcinoma;   Compliance Behavior;   Prevention Harmful Effects
Intervention: Behavioral: Patient Navigation
13 Not yet recruiting Stereotactic Radiotherapy for Oligo-Progressive Non-Small Cell Lung Cancer (STOP-NSCLC)
Condition: Non-Small Cell Lung Cancer
Interventions: Radiation: Stereotactic Ablative Radiotherapy (SABR);   Other: Standard of Care Treatment
14 Recruiting uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung
Conditions: Non-small Cell Lung Cancer;   Malignant Pleural Mesothelioma;   Large Cell Neuroendocrine Carcinoma of the Lung
Intervention: Other: 68Ga-NOTA-AE105 PET/CT
15 Recruiting The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase
Condition: Non-Small-Cell Lung Cancer
Intervention:
16 Not yet recruiting A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer
Conditions: Lung Cancer;   Non-small Cell Lung Cancer
Interventions: Drug: Bevacizumab;   Drug: SB8;   Drug: Carboplatin;   Drug: Paclitaxel
17 Not yet recruiting A Randomized Phase III Study of Palliative Radiation of Advanced Central Tumors With Intentional Avoidance of the Esophagus
Condition: Non-Small Cell Lung Cancer
Interventions: Radiation: Conventional radiotherapy;   Radiation: Esophageal-Sparing Intensity-Modulated Radiotherapy
18 Not yet recruiting Real World Data on Gi(l)Otrif® Dose Adjustment
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Gi(l)otrif®
19 Not yet recruiting Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Microgynon;   Drug: Nintedanib
20 Not yet recruiting A Study to Test Combination Treatments in People With Advanced Non-Small Cell Lung Cancer
Condition: Advanced Cancer
Interventions: Biological: Nivolumab;   Drug: Dasatinib;   Biological: BMS-986016

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years